Page last updated: 2024-11-07

gulonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gulonic acid: RN given refers to (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

gulonic acid : A hexonic acid formed by oxidising the aldehyde group of gulose to a carboxylic acid group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID152304
CHEBI ID87753
SCHEMBL ID338748
MeSH IDM0064399

Synonyms (14)

Synonym
2,3,4,5,6-pentahydroxyhexanoic acid
gulonic acid
86853840-8490-4C46-9A98-0493810BCBC2
(2r,3r,4s,5r)-2,3,4,5,6-pentahydroxyhexanoic acid
AKOS006276377
1hb2h1463q ,
unii-1hb2h1463q
20246-33-7
20246-53-1
SCHEMBL338748
gulonic acid, d-
DTXSID20174090
CHEBI:87753
Q27159899

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"In the present study, NMR-based urinary metabonomic profiles resulting from dosing with widely recognized microsomal enzyme inducers were evaluated in male rats."( Modulation of ascorbic acid metabolism by cytochrome P450 induction revealed by metabonomics and transcriptional profiling.
Aranibar, N; Bhaskaran, V; Gong, L; Lecureux, L; Lehman-McKeeman, L; Nelson, D; Ott, KH; Stryker, S; Vassallo, J, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
gulonic acidA hexonic acid formed by oxidising the aldehyde group of gulose to a carboxylic acid group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Ascorbate Biosynthesis414
Biochemical pathways: part I0466

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (47.37)18.7374
1990's2 (5.26)18.2507
2000's7 (18.42)29.6817
2010's10 (26.32)24.3611
2020's1 (2.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.16 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index51.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]